Management of Microvascular Complications in Secondary Diabetes Associated with Autoimmune Diseases — Case Report

1. Boelaert K, Newby PR, Simmonds MJ, et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease. Am J Med. 2010;123:183.e1-183. e9.10.1016/j.amjmed.2009.06.030Search in Google Scholar

2. Wu JJ, Rowan CG, Bebchuk JD, Anthony MS. No Association Between TNF Inhibitor and Methotrexate Therapy Versus Methotrexate in Changes in Hemoglobin A1C and Fasting Glucose Among Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis Patients. J Drugs Dermatol. 2015;14:159-166.Search in Google Scholar

3. Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol. 2013;9:30.10.1186/1710-1492-9-30Search in Google Scholar

4. Aspden RM. Obesity punches above its weight in osteoarthritis. Nat Rev Rheumatol. 2011;7:65-68.10.1038/nrrheum.2010.123Open DOISearch in Google Scholar

5. Wang H, Wang PB, Chen T, et al. Analysis of clinical characteristics of immune-related dry eye. J Ophthalmol. 2017;2017:8532397.10.1155/2017/8532397Search in Google Scholar

6. Abbouda A, Abicca I, Fabiani C, et al. Psoriasis and psoriatic arthritisrelated uveitis: different ophthalmological manifestations and ocular inflammation features. Semin Ophthalmol. 2016;15:1-6.Search in Google Scholar

7. Yen YC, Weng SF, Lai FJ, Lin YS. Risk of retinal vein occlusion in patients with psoriasis: A population-based cohort study. Retina. 2015;35:1786-1794.10.1097/IAE.0000000000000536Search in Google Scholar

8. Karch A, Thomas SL. Autoimmune thyroiditis as risk factor for stroke. Neurology. 2014;82:1643-1652.10.1212/WNL.0000000000000377Search in Google Scholar

9. Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep. 2006;8:355-363.10.1007/s11926-006-0065-8Search in Google Scholar

10. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: ‘vascular rheumathology’. Arthriris Res Ther. 2008;10:224.10.1186/ar2515Search in Google Scholar

11. Lentz SR. Homocysteine and vascular dysfunction. Life Sci. 1997;61:1205-1215.10.1016/S0024-3205(97)00392-5Open DOISearch in Google Scholar

12. Vu TT, Fredenburgh JC, Weitz JI. Zinc: an important cofactor in haemostasis and thrombosis. Thromb Haemost. 2013;109:421-430.10.1160/TH12-07-046523306381Search in Google Scholar

13. Tlili N, Elfalleh W, Saadaoui E, Khaldi A, Triki S, Nasri N. The caper (Capparis L.): Ethnopharmacology, phytochemical and pharmacological properties. Fitoterapia. 2011;82:93-101.10.1016/j.fitote.2010.09.00620851750Search in Google Scholar